Aorta-CAD vs FibriCheck

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Aorta-CAD

by Imagen Technologies

FibriCheck

by FibriCheck

AI Verdict

Aorta-CAD is a physician-facing AI tool designed to assist in the detection of aortic atherosclerosis and ectasia on chest X-rays, integrating into diagnostic imaging workflows. Conversely, FibriCheck is a patient-facing mobile application for remote heart rhythm monitoring to detect arrhythmias using a smartphone. While both are FDA-cleared cardiology AI solutions, they address different cardiovascular conditions, utilize distinct data inputs (X-rays vs. PPG), and serve different points in the care pathway.

Choose Aorta-CAD if…

Choose Aorta-CAD if your clinical practice requires AI-powered assistance for radiologists and primary care physicians in accurately interpreting chest X-rays for signs of aortic atherosclerosis and ectasia. This tool is ideal for enhancing diagnostic precision within existing imaging workflows, aiming to reduce diagnostic misses of critical aortic conditions.

View Aorta-CAD →

Choose FibriCheck if…

Choose FibriCheck if you need a patient-centric, remote monitoring solution for heart rhythm abnormalities, particularly for detecting and managing arrhythmias like Atrial Fibrillation. This app empowers patients to use their smartphone for regular self-monitoring, providing immediate results and enabling healthcare providers to oversee patient cardiac health remotely.

View FibriCheck →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Aorta-CAD	FibriCheck
Pricing	Contact for pricing	Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer.
Deployment	Cloud-based	Cloud-based (private cloud).
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FibriCheck

FibriCheck (Tool B) leverages the ubiquitous smartphone for direct patient heart rhythm monitoring, making it highly accessible and intuitive for its primary users (patients). While Aorta-CAD (Tool A) offers seamless integration into clinician workflows, FibriCheck's direct patient engagement via a familiar device provides a broader sense of usability for its target audience.

Clinical Value

Aorta-CAD

Aorta-CAD (Tool A) provides specific, quantified clinical study results, demonstrating a 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta. While FibriCheck (Tool B) is medically certified for arrhythmia detection, Tool A offers more explicit and quantified evidence of its clinical impact on diagnostic accuracy.

Pricing & Value

FibriCheck

FibriCheck (Tool B) offers transparent and detailed pricing for end-users and prescribed patients, including monthly/yearly subscriptions and per-measurement options. Aorta-CAD (Tool A) requires direct contact for pricing information, making it impossible to assess its value proposition without further inquiry.

Enterprise Readiness

Aorta-CAD

Aorta-CAD (Tool A) explicitly states it has a Business Associate Agreement (BAA) and emphasizes seamless integration into existing X-ray reading workflows, which are critical for enterprise adoption in healthcare. While FibriCheck (Tool B) is HIPAA compliant and offers a professional portal, its BAA is only implied, and its primary focus is on patient-facing applications, making Tool A slightly stronger for enterprise-level deployment in a clinical setting.

Innovation

FibriCheck

FibriCheck (Tool B) demonstrates higher innovation by utilizing smartphone camera-based PPG technology for medical-grade heart rhythm measurement, transforming a ubiquitous consumer device into a diagnostic tool. Aorta-CAD (Tool A) uses deep learning to enhance traditional radiology diagnostics, which is innovative, but FibriCheck's approach is more disruptive in its delivery of cardiac care.

Support & Docs

Tie

FibriCheck (Tool B) provides publicly accessible user manuals and a help center for both individuals and healthcare providers. While Imagen Technologies (Tool A) would undoubtedly offer support to its enterprise clients, specific details on publicly available documentation or support tiers for Aorta-CAD are not readily available through general web searches. Due to the lack of directly comparable public information for both, it is a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Aorta-CAD	FibriCheck
Name	Aorta-CAD	FibriCheck
Company	Imagen Technologies	Qompium nv
Description	FDA-cleared, cloud-based AI software that assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays, integrating seamlessly into existing workflows.	Medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone.
Primary Users	Physicians (radiologists and PCPs)	Patients (end-users) and Healthcare Providers
Key Detection Focus	Aortic Atherosclerosis and Aortic Ectasia	Arrhythmias (e.g., Atrial Fibrillation)
Input Data	Chest X-rays	Smartphone camera-based PPG technology

Videos

Demos, reviews, and walkthroughs featuring Aorta-CAD and FibriCheck.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How deeply does each tool integrate with existing EHR systems and how does it impact a physician's daily workflow?

Aorta-CAD is designed to seamlessly integrate into existing X-ray reading workflows, providing an overlay with annotations that can be toggled on or off, assisting radiologists and PCPs in interpreting chest X-rays. FibriCheck provides a healthcare professional portal/dashboard for monitoring patient data, supporting remote patient monitoring workflows, but the direct depth of integration with a physician's EHR for automated data flow is not detailed.

What specific clinical evidence supports the accuracy and sensitivity of each tool in detecting the conditions they target?

Aorta-CAD demonstrated a 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta in a clinical study, indicating its effectiveness as a diagnostic aid. FibriCheck utilizes an AI-powered algorithm for arrhythmia detection and analysis, including Atrial Fibrillation, but specific sensitivity and specificity metrics from clinical studies are not provided in the description.

How does each tool specifically cater to the needs of different medical specialties, and what clinical scenarios are they best suited for?

Aorta-CAD is best suited for radiologists and primary care physicians interpreting chest X-rays, aiding in the detection of aortic atherosclerosis and ectasia, relevant to cardiology and internal medicine as a diagnostic assistant for structural heart conditions. FibriCheck is ideal for cardiologists, family medicine practitioners, and internal medicine physicians managing patients requiring remote heart rhythm monitoring, particularly for detecting and monitoring arrhythmias like AFib.

What is the expected learning curve for physicians and their staff, and how quickly can a practice expect to see clinical value from implementing each tool?

Given its seamless integration into existing X-ray workflows and an intuitive overlay feature, the learning curve for Aorta-CAD is likely minimal, allowing for rapid adoption and immediate assistance in diagnostic interpretation. For FibriCheck, the learning curve for physicians would involve familiarization with the professional portal, while patients use a smartphone app, suggesting a relatively quick onboarding for both, leading to prompt initiation of remote monitoring.

What considerations should be made for multi-site rollouts, and are customer references available to assess real-world implementation experiences?

As a cloud-based software, Aorta-CAD should be scalable for multi-site rollouts, though specific implementation support and customer references would need to be inquired directly from Imagen Technologies. FibriCheck, being a cloud-based digital application with a professional portal, is inherently designed for scalable deployment across multiple healthcare providers and clinical centers, but information on customer references is not provided.